A European perspective on immunogenicity evaluation-Reference-Cited by-同舟云学术

A European perspective on immunogenicity evaluation

Published:2009-06 Issue:6 Volume:27 Page:507-508
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Schneider Christian K,Papaluca Marisa,Kurki Pekka

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt0609-507.pdf

Reference4 articles.

1. Shankar, G., Pendley, C. & Stein, K.E. Nat. Biotechnol. 25, 555–561 (2007).

2. European Medicines Agency. Guideline on Immunogenicity Assessment of Biotechnology-derived Therapeutic Proteins EMEA/CHMP/BMWP/14327/2006. < http://www.emea.europa.eu/htms/human/humanguidelines/multidiscipline.htm >

3. BMWP/BWP Workshop on Immunogenicity Assessment of Therapeutic Proteins, EMEA, London, September 4, 2007. < http://www.emea.europa.eu/meetings/conferences/4sep07.htm >

4. European Medicines Agency. European Public Assessment Report (EPAR) for Remicade. < http://www.emea.europa.eu/humandocs/Humans/EPAR/remicade/remicade.htm >

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compatibility of immunogenicity guidance by the EMA and the US FDA;Bioanalysis;2019-09

2. Harmonization and standardization of immunogenicity assessment of biotherapeutic products;Bioanalysis;2019-09

3. Cut point computation in immunogenicity assays: a tutorial;Current Issues in Ligand Binding Assay Bioanalysis;2016-03

4. A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective;Journal of Immunological Methods;2015-02

5. Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals;Bioanalysis;2012-09